CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Argenica Therapeutics Ltd Company Snapshot
Argenica Therapeutics Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Argenica Therapeutics Ltd with three other miscellaneous service companies in Australasia: Antisense Therapeutics Limited (2021 sales of 4,181.00 Australian Dollars [US$3,047.36 ] ), Race Oncology Ltd (18,847.00 Australian Dollars [US$13,736.82 ] ), and Dimerix Ltd (1,506.00 Australian Dollars [US$1,097.66 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Argenica Therapeutics Ltd
  Stock Performance Chart for Argenica Therapeutics Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): .40
(Figures in Australian Dollars)
1 Week 21.2%   13 Weeks 81.8%  
4 Weeks 90.5%   52 Weeks n/a  
 
Argenica Therapeutics Ltd Key Data:
  Ticker: AGN Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 202
(Year Ending Jan 2022).
Employees: N/A
  Currency: Australian Dollars Market Cap: 29,268,900
  Fiscal Yr Ends: June Shares Outstanding: 73,172,250
  Share Type: Ordinary Closely Held Shares: 32,561,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.